64Cu-LNTH-1363S Trial
Phase 1/2
26
about 8 months
15+
5 sites in CA, MI, OH
What this study is about
This trial is testing a new treatment called 64Cu-LNTH-1363S in people with sarcoma or gastrointestinal tract cancer. The goal is to see if this treatment is safe and effective, determine the right dose for imaging, and compare its use to another imaging technique.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 64Cu-LNTH-1363S
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Primary Part 1 - Optimal dose (radioactivity) and imaging time window of 64Cu-LNTH-1363S
Secondary: Secondary Parts 1 and 2 Safety and Tolerability
Oncology